4-AMINO-2-(5-CHLORO-BENZOOXAZOL-2-YL)-PHENOL
|
- $378 - $874
- Product name: 4-AMINO-2-(5-CHLORO-BENZOOXAZOL-2-YL)-PHENOL
- CAS: 293737-93-6
- MF: C13H9ClN2O2
- MW: 260.68
- EINECS:
- MDL Number:MFCD02063071
- Synonyms:ART-CHEM-BB B025306;LABOTEST-BB LT00517660;AKOS BB-8272;4-AMINO-2-(5-CHLORO-BENZOOXAZOL-2-YL)-PHENOL;ASISCHEM T30913;TIMTEC-BB SBB007320;4-Amino-2-(5-chlorobenzo[d]oxazol-2-yl)phenol;Phenol, 4-amino-2-(5-chloro-2-benzoxazolyl)-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 1MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0069843
- Product description4-AMINO-2-(5-CHLORO-BENZOOXAZOL-2-YL)-PHENOL 95.00%
- Packaging1MG
- Price$586.97
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11152391
- Product description4-Amino-2-(5-chlorobenzo[d]oxazol-2-yl)phenol 95+%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number011046
- Product description4-Amino-2-(5-chloro-benzooxazol-2-yl)-phenol
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0069843 | 4-AMINO-2-(5-CHLORO-BENZOOXAZOL-2-YL)-PHENOL 95.00% | 1MG | $586.97 | 2021-12-16 | Buy |
| Crysdot | CD11152391 | 4-Amino-2-(5-chlorobenzo[d]oxazol-2-yl)phenol 95+% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 011046 | 4-Amino-2-(5-chloro-benzooxazol-2-yl)-phenol | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :454.9±40.0 °C(Predicted)
Density :1.468±0.06 g/cm3(Predicted)
pka :8.68±0.43(Predicted)
Density :1.468±0.06 g/cm3(Predicted)
pka :8.68±0.43(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|
